Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02838966 · ClinicalTrials.gov registry record · NA
Preoperative Nutrition With Immune Enhancing Nutritional Supplement (Immunomodulation)
A NA study, sponsored by University of Louisville.
- Terminated
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT02838966 is a NA study that was terminated before completion, run by University of Louisville. The registered enrollment target is 14 participants.
The verdict
NCT02838966, a NA study, was terminated before completion, sponsored by University of Louisville.
- TERMINATED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the optimal effective dose for preoperative nutritional supplementation with immunomodulators on immune function and perioperative outcomes following pancreaticoduodenectomy for pancreatic adenocarcinoma.
Interventions
- DIETARY_SUPPLEMENT Nestle IMPACT Advanced Recovery
- DIETARY_SUPPLEMENT Nestle Boost High Protein Drink
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2014-08 |
| Est. Completion | 2019-11-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02838966
The ClinicalTrials.gov registry entry for NCT02838966 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nestle IMPACT Advanced Recovery is the first listed.
NCT02838966 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02838966 about?
NCT02838966 is a clinical study titled "Preoperative Nutrition With Immune Enhancing Nutritional Supplement (Immunomodulation)". The purpose of this study is to determine the optimal effective dose for preoperative nutritional supplementation with immunomodulators on immune function and perioperative outcomes following pancreaticoduodenectomy for pancreatic adenocarcinoma.
What is the current status of trial NCT02838966?
This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2014-08. Estimated completion is 2019-11-11.
What interventions are being tested in trial NCT02838966?
The interventions under investigation include: Nestle IMPACT Advanced Recovery (DIETARY_SUPPLEMENT), Nestle Boost High Protein Drink (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02838966?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.